✦ LIBER ✦

Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutations

✍ Scribed by Harshabad Singh; Salma Asali; Lillian L. Werner; Daniel J. DeAngelo; Karen K. Ballen; Philip C. Amrein; Martha Wadleigh; Ilene Galinsky; Donna S. Neuberg; Edward A. Fox; Richard M. Stone; Eyal C. Attar

Book ID: 113773463
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 289 KB
Volume: 35
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2011.05.032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutational landscape of AML with normal

Mutational landscape of AML with normal cytogenetics: Biological and clinical implications

✍ Martelli, Maria Paola; Sportoletti, Paolo; Tiacci, Enrico; Martelli, Massimo F.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 435 KB

Comparison of autologous stem cell trans

Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN-AML) and FLT3ITD

✍ Harshabad Singh; Lillian L. Werner; Salma Asali; Daniel J. DeAngelo; Karen K. Ba 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

A rapid, one step assay for simultaneous

A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics

✍ Qin Huang; Wengang Chen; Karl K. Gaal; Marilyn L. Slovak; Anthony Stein; Lawrenc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Genomic, immunophenotypic, and NPM1/FLT3

Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse

✍ Eunice S. Wang; Sheila N.J. Sait; David Gold; Terry Mashtare; Petr Starostik; La 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 353 KB

Prognostic impact, concurrent genetic mu

Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity

✍ Taskesen, E.; Bullinger, L.; Corbacioglu, A.; Sanders, M. A.; Erpelinck, C. A. J 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 254 KB

Favorable prognostic impact of NPM1 gene

Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML

✍ Hollink, I H I M; Zwaan, C M; Zimmermann, M; Arentsen-Peters, T C J M; Pieters, 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 285 KB